Is China Jo-Jo Drugstores, Inc. overvalued or undervalued?
As of October 15, 2023, China Jo-Jo Drugstores, Inc. is considered overvalued with a P/E ratio of 25.4 and a P/B ratio of 3.1, significantly higher than peers like CVS Health and Walgreens, and has underperformed against the Sensex.
As of 15 October 2023, China Jo-Jo Drugstores, Inc. has moved from fair to overvalued. The analysis indicates that the company is currently overvalued given its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 25.4, a Price-to-Book (P/B) ratio of 3.1, and a Return on Equity (ROE) of 12.5%. In comparison to peers, CVS Health Corporation has a P/E ratio of 15.8, while Walgreens Boots Alliance shows a P/B ratio of 1.5, highlighting that China Jo-Jo is trading at a premium relative to its industry counterparts. This overvaluation is further supported by the recent performance of the stock, which has underperformed against the Sensex, reinforcing concerns about its current market price.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
